These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24139487)

  • 41. Trypanosoma brucei and T. vivax: salicylhydroxamic acid and glycerol treatment of acute and chronically infected rats.
    van der Meer C; Versluijs-Broers JA
    Exp Parasitol; 1986 Aug; 62(1):98-113. PubMed ID: 3720904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
    Simarro PP; Asumu PN
    Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
    [No Abstract]   [Full Text] [Related]  

  • 43. Eflornithine for the treatment of human African trypanosomiasis.
    Burri C; Brun R
    Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypanocidal activity of dicationic compounds related to pentamidine.
    Donkor IO; Assefa H; Rattendi D; Lane S; Vargas M; Goldberg B; Bacchi C
    Eur J Med Chem; 2001 Jun; 36(6):531-8. PubMed ID: 11525843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
    Kuemmerle A; Schmid C; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Ngolo D; Kisala M; Valverde Mordt O
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008028. PubMed ID: 31986140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insights into antitrypanosomal drug mode-of-action from cytology-based profiling.
    Thomas JA; Baker N; Hutchinson S; Dominicus C; Trenaman A; Glover L; Alsford S; Horn D
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006980. PubMed ID: 30475806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy against human African trypanosomiasis: is there a road to success?
    Burri C
    Parasitology; 2010 Dec; 137(14):1987-94. PubMed ID: 20961469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter
    Alghamdi AH; Munday JC; Campagnaro GD; Gurvic D; Svensson F; Okpara CE; Kumar A; Quintana J; Martin Abril ME; Milić P; Watson L; Paape D; Settimo L; Dimitriou A; Wielinska J; Smart G; Anderson LF; Woodley CM; Kelly SPY; Ibrahim HM; Hulpia F; Al-Salabi MI; Eze AA; Sprenger T; Teka IA; Gudin S; Weyand S; Field M; Dardonville C; Tidwell RR; Carrington M; O'Neill P; Boykin DW; Zachariae U; De Koning HP
    Elife; 2020 Aug; 9():. PubMed ID: 32762841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment options for second-stage gambiense human African trypanosomiasis.
    Eperon G; Balasegaram M; Potet J; Mowbray C; Valverde O; Chappuis F
    Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1407-17. PubMed ID: 25204360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo evaluation of sixteen plant extracts on mice inoculated with Trypanosoma brucei gambiense.
    Youan BB; Coulibaly S; Miezan TB; Doua F; Bamba M
    Bull World Health Organ; 1997; 75(4):343-8. PubMed ID: 9342893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.
    Kaiser M; Bray MA; Cal M; Bourdin Trunz B; Torreele E; Brun R
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5602-8. PubMed ID: 21911566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human African trypanosomiasis.
    Brun R; Blum J; Chappuis F; Burri C
    Lancet; 2010 Jan; 375(9709):148-59. PubMed ID: 19833383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain.
    Sanderson L; Dogruel M; Rodgers J; Bradley B; Thomas SA
    J Neurochem; 2008 Nov; 107(4):1136-46. PubMed ID: 18823367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis.
    Simarro PP; Franco J; Diarra A; Postigo JA; Jannin J
    Parasitology; 2012 Jun; 139(7):842-6. PubMed ID: 22309684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of human African trypanosomiasis.
    Dumas M; Bouteille B
    Bull World Health Organ; 2000; 78(12):1474. PubMed ID: 11196500
    [No Abstract]   [Full Text] [Related]  

  • 57. Trypanosoma lewisi: study of the activity of lonidamine in vitro and in vivo in rats.
    Manganaro M; Luparini MR; Ricciolini R; Calio F; Miccheli A; Conti F
    Cell Mol Biol; 1988; 34(5):517-28. PubMed ID: 3069222
    [No Abstract]   [Full Text] [Related]  

  • 58. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.